Resident Cardiac Stem Cells and Their Role in Stem Cell Therapies for Myocardial Repair

Canadian Journal of Cardiology

Volumn 30, Issue 11, 2014, Pages 1288-1298

  Mayfield, Audrey E ^a   Tilokee, Everad L ^a   Davis, Darryl R ^a  

^a UNIVERSITY OF OTTAWA HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIAC STEM CELL; CELL PROLIFERATION; CELL RENEWAL; EX VIVO STUDY; HEART FAILURE; HEART MUSCLE CELL; HEART VENTRICLE FUNCTION; HUMAN; META ANALYSIS (TOPIC); NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STEM CELL TRANSPLANTATION; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; HEART MUSCLE; MYOCARDIAL INFARCTION; PATHOLOGY; PROCEDURES;

CELL DIFFERENTIATION; CELLS, CULTURED; HEART FAILURE; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; STEM CELL TRANSPLANTATION;

EID: 84908507587     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2014.03.018     Document Type: Review

References (123)

1. Cardiovascular Health and Services in Ontario: An ICES Atlas 1999, Institute for Clinical Evaluative Sciences, Toronto. C.D. Naylor, P.M. Slaughter (Eds.).
2. Alter D.A., Ko D.T., Tu J.V., et al. The average lifespan of patients discharged from hospital with heart failure. JGen Intern Med 2012, 27:1171-1179.
3. Lee D.S., Schull M.J., Alter D.A., et al. Early deaths in patients with heart failure discharged from the emergency department: a population-based analysis. Circ Heart Fail 2010, 3:228-235.
4. Bergmann O., Bhardwaj R.D., Bernard S., et al. Evidence for cardiomyocyte renewal in humans. Science 2009, 324:98-102.
5. Strauer B.E., Brehm M., Zeus T., et al. Intracoronary, human autologous stem cell transplantation for myocardial regeneration following myocardial infarction [in German]. Dtsch Med Wochenschr 2001, 126:932-938.
6. Orlic D., Kajstura J., Chimenti S., et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001, 410:701-705.
7. Murry C.E., Soonpaa M.H., Reinecke H., et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004, 428:664-668.
8. Balsam L.B., Wagers A.J., Christensen J.L., et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004, 428:668-673.
9. Jeevanantham V., Butler M., Saad A., et al. Adult bone marrow cell therapy improves survival and induces long-term improvement in cardiac parameters: a systematic review and meta-analysis. Circulation 2012, 126:551-568.
10. Chavakis E., Koyanagi M., Dimmeler S. Enhancing the outcome of cell therapy for cardiac repair: progress from bench to bedside and back. Circulation 2010, 121:325-335.
11. Wang W., Jiang Q., Zhang H., et al. Intravenous administration of bone marrow mesenchymal stromal cells is safe for the lung in a chronic myocardial infarction model. Regen Med 2011, 6:179-190.
12. Jiang Q., Song P., Wang E., et al. Remote ischemic postconditioning enhances cell retention in the myocardium after intravenous administration of bone marrow mesenchymal stromal cells. JMol Cell Cardiol 2013, 56:1-7.
13. Menasche P., Hagege A.A., Vilquin J.T., et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. JAm Coll Cardiol 2003, 41:1078-1083.
14. Hagege A.A., Carrion C., Menasche P., et al. Viability and differentiation of autologous skeletal myoblast grafts in ischaemic cardiomyopathy. Lancet 2003, 361:491-492.
15. Siminiak T., Kalawski R., Fiszer D., et al. Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up. Am Heart J 2004, 148:531-537.
16. Katritsis D.G., Sotiropoulou P., Giazitzoglou E., Karvouni E., Papamichail M. Electrophysiological effects of intracoronary transplantation of autologous mesenchymal and endothelial progenitor cells. Europace 2007, 9:167-171.
17. Morkin E., Ashford T.P. Myocardial DNA synthesis in experimental cardiac hypertrophy. Am J Physiol 1968, 215:1409-1413.
18. Grove D., Nair K.G., Zak R. Biochemical correlates of cardiac hypertrophy. 3. Changes in DNA content; the relative contributions of polyploidy and mitotic activity. Circ Res 1969, 25:463-471.
19. Grove D., Zak R., Nair K.G., Aschenbrenner V. Biochemical correlates of cardiac hypertrophy. IV. Observations on the cellular organization of growth during myocardial hypertrophy in the rat. Circ Res 1969, 25:473-485.
20. Kajstura J., Gurusamy N., Ogorek B., et al. Myocyte turnover in the aging human heart. Circ Res 2010, 107:1374-1386.
21. Kajstura J., Urbanek K., Rota M., et al. Cardiac stem cells and myocardial disease. JMol Cell Cardiol 2008, 45:505-513.
22. Chien K.R., Olson E.N. Converging pathways and principles in heart development and disease: CV@CSH. Cell 2002, 110:153-162.
23. Porrello E.R., Mahmoud A.I., Simpson E., et al. Transient regenerative potential of the neonatal mouse heart. Science 2011, 331:1078-1080.
24. Thorgeirsson S.S. Hepatic stem cells in liver regeneration. FASEB J 1996, 10:1249-1256.
25. Bjornson C.R., Rietze R.L., Reynolds B.A., Magli M.C., Vescovi A.L. Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells invivo. Science 1999, 283:534-537.
26. Hierlihy A.M., Seale P., Lobe C.G., Rudnicki M.A., Megeney L.A. The post-natal heart contains a myocardial stem cell population. FEBS Lett 2002, 530:239-243.
27. Pfister O., Oikonomopoulos A., Sereti K.I., et al. Role of the ATP-binding cassette transporter Abcg2 in the phenotype and function of cardiac side population cells. Circ Res 2008, 103:825-835.
28. Meissner K., Heydrich B., Jedlitschky G., et al. The ATP-binding cassette transporter ABCG2 (BCRP), a marker for side population stem cells, is expressed in human heart. JHistochem Cytochem 2006, 54:215-221.
29. Martin C.M., Meeson A.P., Robertson S.M., et al. Persistent expression of the ATP-binding cassette transporter, Abcg2, identifies cardiac SP cells in the developing and adult heart. Dev Biol 2004, 265:262-275.
30. Alfakir M., Dawe N., Eyre R., et al. The temporal and spatial expression patterns of ABCG2 in the developing human heart. Int J Cardiol 2012, 156:133-138.
31. Nagai T., Matsuura K., Komuro I. Cardiac side population cells and Sca-1-positive cells. Methods Mol Biol 2013, 1036:63-74.
32. Wang X., Hu Q., Nakamura Y., et al. The role of the sca-1+/. Stem Cells 2006, 24:1779-1788.
33. Bailey B., Fransioli J., Gude N.A., et al. Sca-1 knockout impairs myocardial and cardiac progenitor cell function. Circ Res 2012, 111:750-760.
34. Beltrami A.P., Barlucchi L., Torella D., et al. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 2003, 114:763-776.
35. D'Amario D., Fiorini C., Campbell P.M., et al. Functionally competent cardiac stem cells can be isolated from endomyocardial biopsies of patients with advanced cardiomyopathies. Circ Res 2011, 108:857-861.
36. Urbanek K., Cesselli D., Rota M., et al. Stem cell niches in the adult mouse heart. Proc Natl Acad Sci U S A 2006, 103:9226-9231.
37. Davis D.R., Kizana E., Terrovitis J., et al. Isolation and expansion of functionally-competent cardiac progenitor cells directly from heart biopsies. JMol Cell Cardiol 2010, 49:312-321.
38. Latham N., Ye B., Jackson R., et al. Human blood and cardiac stem cells synergize to enhance cardiac repair when cotransplanted into ischemic myocardium. Circulation 2013, 128(11 suppl 1):S105-S112.
39. Mayfield A.E., Tilokee E.L., Latham N., et al. The effect of encapsulation of cardiac stem cells within matrix-enriched hydrogel capsules on cell survival, post-ischemic cell retention and cardiac function. Biomaterials 2014, 35:133-142.
40. Messina E., De A.L., Frati G., et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res 2004, 95:911-921.
41. Davis D.R., Zhang Y., Smith R.R., et al. Validation of the cardiosphere method to culture cardiac progenitor cells from myocardial tissue. PLoS One 2009, 4:e7195.
42. Smith R.R., Barile L., Cho H.C., et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 2007, 115:896-908.
43. Malliaras K., Makkar R.R., Smith R.R., et al. Intracoronary cardiosphere-derived cells after myocardial infarction: evidence of therapeutic regeneration in the final 1-year results of the CADUCEUS trial (CArdiosphere-Derived aUtologous stem CElls to reverse ventricUlar dySfunction). JAm Coll Cardiol 2014, 63:110-122.
44. Bearzi C., Rota M., Hosoda T., et al. Human cardiac stem cells. Proc Natl Acad Sci U S A 2007, 104:14068-14073.
45. Bolli R., Chugh A.R., D'Amario D., et al. Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial. Lancet 2011, 378:1847-1857.
46. Ferreira-Martins J., Ogorek B., Cappetta D., et al. Cardiomyogenesis in the developing heart is regulated by c-kit-positive cardiac stem cells. Circ Res 2012, 110:701-715.
47. Ferreira-Martins J., Rondon-Clavo C., Tugal D., et al. Spontaneous calcium oscillations regulate human cardiac progenitor cell growth. Circ Res 2009, 105:764-774.
48. Hsieh P.C., Segers V.F., Davis M.E., et al. Evidence from a genetic fate-mapping study that stem cells refresh adult mammalian cardiomyocytes after injury. Nat Med 2007, 13:970-974.
49. Poss K.D., Wilson L.G., Keating M.T. Heart regeneration in zebrafish. Science 2002, 298:2188-2190.
50. Fransioli J., Bailey B., Gude N.A., et al. Evolution of the c-kit-positive cell response to pathological challenge in the myocardium. Stem Cells 2008, 26:1315-1324.
51. Chimenti I., Smith R.R., Li T.S., et al. Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice. Circ Res 2010, 106:971-980.
52. Zakharova L., Nural-Guvener H., Gaballa M.A. Cardiac explant-derived cells are regulated by Notch-modulated mesenchymal transition. PLoS One 2012, 7:e37800.
53. Davis D.R., Ruckdeschel S.R., Marban E. Human cardiospheres are a source of stem cells with cardiomyogenic potential. Stem Cells 2010, 28:903-904.
54. Cho H.J., Lee H.J., Chung Y.J., et al. Generation of human secondary cardiospheres as a potent cell processing strategy for cell-based cardiac repair. Biomaterials 2013, 34:651-661.
55. Cho H.J., Lee H.J., Youn S.W., et al. Secondary sphere formation enhances the functionality of cardiac progenitor cells. Mol Ther 2012, 20:1750-1766.
56. Shen D., Cheng K., Marban E. Dose-dependent functional benefit of human cardiosphere transplantation in mice with acute myocardial infarction. JCell Mol Med 2012, 16:2112-2116.
57. Lee S.T., White A.J., Matsushita S., et al. Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction. JAm Coll Cardiol 2011, 57:455-465.
58. Malliaras K., Li T.S., Luthringer D., et al. Safety and efficacy of allogeneic cell therapy in infarcted rats transplanted with mismatched cardiosphere-derived cells. Circulation 2012, 125:100-112.
59. Li T.S., Cheng K., Malliaras K., et al. Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells. JAm Coll Cardiol 2012, 59:942-953.
60. Johnston P.V., Sasano T., Mills K., et al. Engraftment, differentiation, and functional benefits of autologous cardiosphere-derived cells in porcine ischemic cardiomyopathy. Circulation 2009, 120:1075-1083. 1087.
61. Bonios M., Terrovitis J., Chang C.Y., et al. Myocardial substrate and route of administration determine acute cardiac retention and lung bio-distribution of cardiosphere-derived cells. JNucl Cardiol 2011, 18:443-450.
62. Makkar R.R., Smith R.R., Cheng K., et al. Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial. Lancet 2012, 379:895-904.
63. Chugh A.R., Beache G.M., Loughran J.H., et al. Administration of cardiac stem cells in patients with ischemic cardiomyopathy: the SCIPIO trial: surgical aspects and interim analysis of myocardial function and viability by magnetic resonance. Circulation 2012, 126(11 suppl 1):S54-S64.
64. Rubio D., Garcia-Castro J., Martin M.C., et al. Spontaneous human adult stem cell transformation. Cancer Res 2005, 65:3035-3039.
65. Ott H.C., Matthiesen T.S., Brechtken J., et al. The adult human heart as a source for stem cells: repair strategies with embryonic-like progenitor cells. Nat Clin Pract Cardiovasc Med 2007, 4(suppl 1):S27-S39.
66. Pavlova S.V., Perovskii P.P., Chepeleva E.V., et al. Characteristics of cardiac cell cultures derived from human myocardial explants. Bull Exp Biol Med 2013, 156:127-135.
67. Li Z., Lee A., Huang M., et al. Imaging survival and function of transplanted cardiac resident stem cells. JAm Coll Cardiol 2009, 53:1229-1240.
68. White A.J., Smith R.R., Matsushita S., et al. Intrinsic cardiac origin of human cardiosphere-derived cells. Eur Heart J 2013, 34:68-75.
69. Guan K., Hasenfuss G. Do stem cells in the heart truly differentiate into cardiomyocytes?. JMol Cell Cardiol 2007, 43:377-387.
70. Dimmeler S., Burchfield J., Zeiher A.M. Cell-based therapy of myocardial infarction. Arterioscler Thromb Vasc Biol 2008, 28:208-216.
71. Menasche P., Alfieri O., Janssens S., et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 2008, 117:1189-1200.
72. D'Alessandro D.A., Kajstura J., Hosoda T., et al. Progenitor cells from the explanted heart generate immunocompatible myocardium within the transplanted donor heart. Circ Res 2009, 105:1128-1140.
73. Terrovitis J., Lautamaki R., Bonios M., et al. Noninvasive quantification and optimization of acute cell retention by invivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery. JAm Coll Cardiol 2009, 54:1619-1626.
74. Terrovitis J.V., Smith R.R., Marban E. Assessment and optimization of cell engraftment after transplantation into the heart. Circ Res 2010, 106:479-494.
75. Terrovitis J., Kwok K.F., Lautamaki R., et al. Ectopic expression of the sodium-iodide symporter enables imaging of transplanted cardiac stem cells invivo by single-photon emission computed tomography or positron emission tomography. JAm Coll Cardiol 2008, 52:1652-1660.
76. Karoubi G., Ormiston M.L., Stewart D.J., Courtman D.W. Single-cell hydrogel encapsulation for enhanced survival of human marrow stromal cells. Biomaterials 2009, 30:5445-5455.
77. Malliaras K., Zhang Y., Seinfeld J., et al. Cardiomyocyte proliferation and progenitor cell recruitment underlie therapeutic regeneration after myocardial infarction in the adult mouse heart. EMBO Mol Med 2013, 5:191-209.
78. Tseliou E., de Couto G., Terrovitis J., Sun B., Weixin L., Marban L., Marban E. Angiogenesis, cardiomyocyte proliferation and anti-fibrotic effects underlie structural preservation post-infarction by intramyocardially-injected cardiospheres. PLoS One 2014, 9:e88590.
79. Vrijsen K.R., Sluijter J.P., Schuchardt M.W., et al. Cardiomyocyte progenitor cell-derived exosomes stimulate migration of endothelial cells. JCell Mol Med 2010, 14:1064-1070.
80. Arslan F., Lai R.C., Smeets M.B., et al. Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. Stem Cell Res 2013, 10:301-312.
81. Barile L., Gherghiceanu M., Popescu L.M., Moccetti T., Vassalli G. Ultrastructural evidence of exosome secretion by progenitor cells in adult mouse myocardium and adult human cardiospheres. JBiomed Biotechnol 2012, 2012:354605.
82. Davis D.R., Stewart D.J. Autologous cell therapy for cardiac repair. Expert Opin Biol Ther 2011, 11:489-508.
83. Erbs S., Linke A., Schachinger V., et al. Restoration of microvascular function in the infarct-related artery by intracoronary transplantation of bone marrow progenitor cells in patients with acute myocardial infarction: the Doppler Substudy of the Reinfusion of Enriched Progenitor Cells and Infarct Remodeling in Acute Myocardial Infarction (REPAIR-AMI) trial. Circulation 2007, 116:366-374.
84. Herbots L., D'hooge J., Eroglu E., et al. Improved regional function after autologous bone marrow-derived stem cell transfer in patients with acute myocardial infarction: a randomized, double-blind strain rate imaging study. Eur Heart J 2009, 30:662-670.
85. Strauer B.E., Brehm M., Zeus T., et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002, 106:1913-1918.
86. Lunde K., Solheim S., Aakhus S., et al. Autologous stem cell transplantation in acute myocardial infarction: the ASTAMI randomized controlled trial. Intracoronary transplantation of autologous mononuclear bone marrow cells, study design and safety aspects. Scand Cardiovasc J 2005, 39:150-158.
87. Tendera M., Wojakowski W., Ruzyllo W., et al. Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. Eur Heart J 2009, 30:1313-1321.
88. Traverse J.H., Henry T.D., Pepine C.J., et al. Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial. JAMA 2012, 308:2380-2389.
89. Bolli R., Tang X.L., Sanganalmath S.K., et al. Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy. Circulation 2013, 128:122-131.
90. Takehara N., Tsutsumi Y., Tateishi K., et al. Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction. JAm Coll Cardiol 2008, 52:1858-1865.
91. Takehara N. The ALCADIA (Autologous Human Cardiac-derived Stem Cell To Treat Ischemic Cardiomyopathy) trial. American Heart Association,2012. Available at: . Accessed May 20, 2014. http://my.americanheart.org/professional/Sessions/ScientificSessions/ScienceNews/SS12-Late-Breaking-Clinical-Trials_UCM_432888_Article.jsp.
92. Lee D.S., Johansen H., Gong Y., et al. Regional outcomes of heart failure in Canada. Can J Cardiol 2004, 20:599-607.
93. Traverse J.H., Henry T.D., Ellis S.G., et al. Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. JAMA 2011, 306:2110-2119.
94. Tang X.L., Rokosh G., Sanganalmath S.K., et al. Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction. Circulation 2010, 121:293-305.
95. Welt F.G., Gallegos R., Connell J., et al. Effect of cardiac stem cells on left-ventricular remodeling in a canine model of chronic myocardial infarction. Circ Heart Fail 2013, 6:99-106.
96. Amado L.C., Saliaris A.P., Schuleri K.H., et al. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A 2005, 102:11474-11479.
97. Hare J.M., Fishman J.E., Gerstenblith G., et al. Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA 2012, 308:2369-2379.
98. Huang X.P., Sun Z., Miyagi Y., et al. Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair. Circulation 2010, 122:2419-2429.
99. Cheng K., Malliaras K., Li T.S., et al. Magnetic enhancement of cell retention, engraftment, and functional benefit after intracoronary delivery of cardiac-derived stem cells in a rat model of ischemia/reperfusion. Cell Transplant 2012, 21:1121-1135.
100. Zhang Y., Thorn S., DaSilva J.N., et al. Collagen-based matrices improve the delivery of transplanted circulating progenitor cells: development and demonstration by exvivo radionuclide cell labeling and invivo tracking with positron-emission tomography. Circ Cardiovasc Imaging 2008, 1:197-204.
101. Kuraitis D., Hou C., Zhang Y., et al. Exvivo generation of a highly potent population of circulating angiogenic cells using a collagen matrix. JMol Cell Cardiol 2011, 51:187-197.
102. Kuraitis D., Ebadi D., Zhang P., et al. Injected matrix stimulates myogenesis and regeneration of mouse skeletal muscle after ischaemic injury. Eur Cell Mater 2012, 24:175-195.
103. Cheng K., Shen D., Smith J., et al. Transplantation of platelet gel spiked with cardiosphere-derived cells boosts structural and functional benefits relative to gel transplantation alone in rats with myocardial infarction. Biomaterials 2012, 33:2872-2879.
104. Cheng K., Blusztajn A., Shen D., et al. Functional performance of human cardiosphere-derived cells delivered in an in situ polymerizable hyaluronan-gelatin hydrogel. Biomaterials 2012, 33:5317-5324.
105. Li Z., Guo X., Matsushita S., Guan J. Differentiation of cardiosphere-derived cells into a mature cardiac lineage using biodegradable poly(N-isopropylacrylamide) hydrogels. Biomaterials 2011, 32:3220-3232.
106. Zakharova L., Mastroeni D., Mutlu N., et al. Transplantation of cardiac progenitor cell sheet onto infarcted heart promotes cardiogenesis and improves function. Cardiovasc Res 2010, 87:40-49.
107. Lim S.Y., Kim Y.S., Ahn Y., et al. The effects of mesenchymal stem cells transduced with Akt in a porcine myocardial infarction model. Cardiovasc Res 2006, 70:530-542.
108. Cho J., Zhai P., Maejima Y., Sadoshima J. Myocardial injection with GSK-3beta-overexpressing bone marrow-derived mesenchymal stem cells attenuates cardiac dysfunction after myocardial infarction. Circ Res 2011, 108:478-489.
109. Li W., Ma N., Ong L.L., et al. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells 2007, 25:2118-2127.
110. Mangi A.A., Noiseux N., Kong D., et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003, 9:1195-1201.
111. Yau T.M., Kim C., Li G., et al. Maximizing ventricular function with multimodal cell-based gene therapy. Circulation 2005, 112:I123-I128.
112. Yin Q., Jin P., Liu X., et al. SDF-1alpha inhibits hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells through PI3K/Akt and ERK1/2 signaling pathways. Mol Biol Rep 2011, 38:9-16.
113. Cheng Z., Ou L., Zhou X., et al. Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance. Mol Ther 2008, 16:571-579.
114. Yau T.M., Li G., Weisel R.D., et al. Vascular endothelial growth factor transgene expression in cell-transplanted hearts. JThorac Cardiovasc Surg 2004, 127:1180-1187.
115. Yang J., Zhou W., Zheng W., et al. Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction. Cardiology 2007, 107:17-29.
116. Sun L., Cui M., Wang Z., et al. Mesenchymal stem cells modified with angiopoietin-1 improve remodeling in a rat model of acute myocardial infarction. Biochem Biophys Res Commun 2007, 357:779-784.
117. Yau T.M., Kim C., Ng D., et al. Increasing transplanted cell survival with cell-based angiogenic gene therapy. Ann Thorac Surg 2005, 80:1779-1786.
118. Fischer K.M., Cottage C.T., Wu W., et al. Enhancement of myocardial regeneration through genetic engineering of cardiac progenitor cells expressing Pim-1 kinase. Circulation 2009, 120:2077-2087.
119. Mohsin S., Khan M., Toko H., et al. Human cardiac progenitor cells engineered with Pim-I kinase enhance myocardial repair. JAm Coll Cardiol 2012, 60:1278-1287.
120. Lan F., Liu J., Narsinh K.H., et al. Safe genetic modification of cardiac stem cells using a site-specific integration technique. Circulation 2012, 126(11 suppl 1):S20-S28.
121. Gaspar V.M., Maia C.J., Queiroz J.A., et al. Improved minicircle DNA biosynthesis for gene therapy applications. Hum Gene Ther Methods 2014, 2:93-105.
122. Cho H.J., Lee N., Lee J.Y., et al. Role of host tissues for sustained humoral effects after endothelial progenitor cell transplantation into the ischemic heart. JExp Med 2007, 204:3257-3269.
123. Abdel-Latif A., Bolli R., Tleyjeh I.M., et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 2007, 167:989-997.